- Home
- AMRK vs PRAX Comparison
AMRK vs PRAX Comparison
Compare AMRK & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRK
- PRAX
- Stock Information
- Founded
- AMRK 1965
- PRAX 2015
- Country
- AMRK United States
- PRAX United States
- Employees
- AMRK N/A
- PRAX N/A
- Industry
- AMRK Other Specialty Stores
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- AMRK Industrials
- PRAX Health Care
- Exchange
- AMRK Nasdaq
- PRAX Nasdaq
- Market Cap
- AMRK 524.3M
- PRAX 599.7M
- IPO Year
- AMRK N/A
- PRAX 2020
- Fundamental
- Price
- AMRK $24.20
- PRAX $50.36
- Analyst Decision
- AMRK Buy
- PRAX Strong Buy
- Analyst Count
- AMRK 3
- PRAX 10
- Target Price
- AMRK $33.00
- PRAX $101.00
- AVG Volume (30 Days)
- AMRK 264.0K
- PRAX 305.1K
- Earning Date
- AMRK 08-28-2025
- PRAX 08-12-2025
- Dividend Yield
- AMRK 3.34%
- PRAX N/A
- EPS Growth
- AMRK N/A
- PRAX N/A
- EPS
- AMRK 1.57
- PRAX N/A
- Revenue
- AMRK $10,991,521,000.00
- PRAX $8,122,000.00
- Revenue This Year
- AMRK $19.62
- PRAX N/A
- Revenue Next Year
- AMRK $2.80
- PRAX $6,358.50
- P/E Ratio
- AMRK $15.24
- PRAX N/A
- Revenue Growth
- AMRK 6.78
- PRAX 270.02
- 52 Week Low
- AMRK $19.39
- PRAX $26.70
- 52 Week High
- AMRK $47.39
- PRAX $91.83
- Technical
- Relative Strength Index (RSI)
- AMRK 65.40
- PRAX 71.71
- Support Level
- AMRK $21.91
- PRAX $45.70
- Resistance Level
- AMRK $24.06
- PRAX $53.35
- Average True Range (ATR)
- AMRK 0.79
- PRAX 2.51
- MACD
- AMRK 0.25
- PRAX 0.55
- Stochastic Oscillator
- AMRK 95.17
- PRAX 76.02
About AMRK A-Mark Precious Metals Inc.
A-Mark Precious Metals Inc is a precious metal trading company. It is principally engaged in the wholesale of gold, silver, platinum, copper, and palladium bullion and related products in the form of bars, wafers, coins, and grains. The company's operating segment includes Wholesale Sales and Ancillary Services; Secured Lending and Direct-to-Consumer. It generates maximum revenue from the Wholesale Trading and Ancillary Services segment. The Wholesale Trading and Ancillary Services segment comprises business units such as Industrial, Coin and Bar, Trading and Finance, Storage, Logistics, and Mint. Geographically, it derives a majority of its revenue from the United States and the rest from Europe, Asia Pacific, Australia, Africa, and other regions.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.